MODERATOR(S)
Colette Shen, MD, PhD - University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center
James Bates, MD - Emory University
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
03:00pm - 03:05pm ETSpeaker: James Bates, MD - Emory University, Atlanta
-
03:05pm - 03:10pm ET
Ten-Year Outcomes of Elective Upper-Neck vs. Whole-Neck Irradiation for the Uninvolved Neck in Nasopharyngeal Carcinoma Patients with N0-1 or Unilateral N3 Disease and High Pretreatment Plasma Epstein-Barr Virus DNA Load
Speaker: Linglong Tang, MD, PhD - Sun Yat-Sen University Cancer Center, Guangzhou -
03:10pm - 03:15pm ET
A Multicenter, Randomized Controlled Phase III Trial of TPF Induction Chemotherapy vs. PF Adjuvant Chemotherapy Combined with Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: Long-Term Follow-up Analysis
Speaker: Feng Jin, BS - Affiliated Hospital of Guizhou Medical University, Guiyang -
03:15pm - 03:20pm ET
Evaluating Changes in Tumor Volumes Following Expert Interpretation of Planning Imaging in Head and Neck Cancer Radiotherapy
Speaker: Colin Belliveau, MD - Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal -
03:20pm - 03:25pm ET
Stereotactic Body Radiotherapy Combined with Chemotherapy and PD-1 Inhibitor in Oligometastatic Nasopharyngeal Carcinoma (STOMP): A Prospective Phase II Clinical Trial
Speaker: Jingjing Miao, PhD, MS, BS - Sun Yat-sen University Cancer Center, Guangzhou -
03:25pm - 03:30pm ETSpeaker: Yingzhi Wu, MSN - Memorial Sloan Kettering Cancer Center, New York
-
03:30pm - 03:35pm ET
Proton Beam Therapy vs. IMRT for Nasopharyngeal Carcinoma: Differential Late Toxicity Profile at 5 Years
Speaker: Nima Taghizadeh Mortezaei, MD - Mass General Brigham, Harvard Medical School, Boston -
03:35pm - 03:55pm ETSpeaker: Colette Shen, MD, PhD - University of North Carolina School of Medicine & Lineberger Comprehensive Cancer Center, Chapel Hill
-
03:55pm - 04:00pm ETSpeaker: James Bates, MD - Emory University, Atlanta